H-2-RESTRICTION OF ADOPTIVE IMMUNOTHERAPY OF ESTABLISHED TUMORS

被引:0
|
作者
GREENBERG, PD
CHEEVER, MA
FEFER, A
机构
[1] UNIV WASHINGTON,SEATTLE,WA 98195
[2] HUTCHINSON CANC CTR,SEATTLE,WA 98195
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:281 / 281
页数:1
相关论文
共 50 条
  • [41] STUDIES ON THE GENERATION AND EXPRESSION OF H-2-CONTROLLED T-HELPER FUNCTION IN CHIMERIC MICE - EVIDENCE FOR 2 LEVELS OF H-2-RESTRICTION
    HUNIG, T
    SCHIMPL, A
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1979, 9 (09) : 730 - 736
  • [42] EVALUATION OF H-2-RESTRICTION IN THE T-CELL RECOGNITION OF MLS C AND DM-1 ANTIGENS
    GRESS, R
    HODES, R
    FEDERATION PROCEEDINGS, 1981, 40 (03) : 958 - 958
  • [43] COMBINED CHEMO-IMMUNOTHERAPY OF ESTABLISHED MURINE TUMORS
    TANAKA, T
    PELLIS, NR
    KAHAN, BD
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 287 - 287
  • [44] COMPLEMENTATION OF IR GENES IN RESPONSIVENESS OF MICE TO INSULIN AND H-2-RESTRICTION IN MACROPHAGE-T-CELL INTERACTION
    SPAETH, E
    RUDE, E
    ZEITSCHRIFT FUR IMMUNITATSFORSCHUNG-IMMUNOBIOLOGY, 1979, 156 (03): : 262 - 262
  • [45] HAPTENS CAN SERVE AS SURROGATE TRANSPLANTATION ANTIGENS IN A MANNER THAT DEMONSTRATES H-2-RESTRICTION OF GRAFT-REJECTION
    STREILEIN, JW
    BERGSTRESSER, PR
    JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 157 (04): : 1354 - 1359
  • [46] ANTIGEN-SPECIFIC MURINE T-CELL LYMPHOMAS .2. H-2-RESTRICTION OF PRIMARY AND SECONDARY RESPONSES
    BENSASSON, SZ
    SAITO, H
    UCHIDA, T
    DORF, ME
    CELLULAR IMMUNOLOGY, 1984, 89 (02) : 290 - 299
  • [47] LOCAL ADOPTIVE IMMUNOTHERAPY OF ADVANCED HEAD AND NECK TUMORS WITH LAK CELLS AND INTERLEUKIN-2
    SQUADRELLISARACENO, M
    RIVOLTINI, L
    CANTU, G
    RAVAGNANI, F
    PARMIANI, G
    MOLINARI, R
    TUMORI, 1990, 76 (06) : 566 - 571
  • [48] Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice
    Sally M. Amos
    Hollie J. Pegram
    Jennifer A. Westwood
    Liza B. John
    Christel Devaud
    Chris J. Clarke
    Nicholas P. Restifo
    Mark J. Smyth
    Phillip K. Darcy
    Michael H. Kershaw
    Cancer Immunology, Immunotherapy, 2011, 60 : 671 - 683
  • [49] IMMUNOTHERAPY OF ESTABLISHED PULMONARY MELANOMA METASTASES BY ADOPTIVE TRANSFER OF INTERLEUKIN-2 (IL-2) ACTIVATED SYNGENEIC LYMPHOCYTES
    MAZUMDER, A
    ROSENBERG, SA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 262 - 262
  • [50] Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice
    Amos, Sally M.
    Pegram, Hollie J.
    Westwood, Jennifer A.
    John, Liza B.
    Devaud, Christel
    Clarke, Chris J.
    Restifo, Nicholas P.
    Smyth, Mark J.
    Darcy, Phillip K.
    Kershaw, Michael H.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (05) : 671 - 683